Important things to know about humanoids By Investing.com

Barclays sees the humanoid robotics market reaching as much as $200 billion by 2035, with the broader physical AI ecosystem potentially worth up to $1 trillion. Industry deployments are estimated at about 15,000 units in 2025 and could rise to 60,000 in 2026 as costs fall from roughly $3 million per robot historically to around $100,000 today. Near-term adoption is expected to center on manufacturing, logistics, warehousing, construction, and agriculture before expanding into healthcare and household use.

Analysis

This is less a single-product story than an industrial stack story: the first durable monetization likely accrues to the picks-and-shovels layer, not the robot OEMs. If deployment ramps from a few tens of thousands of units to materially higher volumes, the bottleneck shifts to actuators, power management, motor control, sensor fusion, and manufacturing yield — areas where margins can expand faster than in the finished-robot market, which will be structurally price-competitive.

The second-order winner is likely to be battery and power-density suppliers, because humanoids are energy-constrained by runtime, weight, and cycle life. That creates a hidden link to EV supply chains: incremental demand for high-performance cells, compact packs, and thermal management can become a stealth growth vector even if robot unit sales stay below the hype curve. In contrast, pure-play humanoid names are vulnerable to a classic commercialization gap: pilot deployments can validate the concept while still failing to support profitability for years.

The timeline matters. Over the next 6-18 months, the market will likely overprice near-term unit growth while underestimating integration frictions — safety certification, uptime, maintenance, and software reliability are the gating factors that determine whether labor substitution is economic at scale. The contrarian view is that the true adoption inflection may be slower than headline TAM implies, but once a few high-volume use cases standardize, the winners can compound quickly because humanoids can be replicated across facilities without bespoke retooling.

The cleanest trade is to express the theme through upstream enablers and avoid paying peak multiple risk for narrative stocks. A more aggressive variant is a relative-value basket versus broad industrial automation, since humanoids should cannibalize some legacy robot demand while expanding the total addressable market in labor-constrained sectors. Watch for catalyst risk around pilot-to-production conversion rates and any evidence that Chinese supply-chain pricing is compressing margins faster than Western incumbents can scale.

Key Decisions for Investors

• Go long a basket of robotics-enabler suppliers on a 6-12 month horizon: NVDA (AI compute), ALB or SQM (battery materials exposure), and a quality industrial automation name with actuator exposure; target a 15-25% upside if deployment accelerates faster than consensus, with downside limited by diversified end-market demand.
• Avoid chasing pure-play humanoid OEMs until unit economics are visible; if exposure is required, size it as a small momentum trade only and use a 3-6 month stop if pilot-to-production conversion stalls.
• Pair trade: long robotics components / short legacy factory automation basket over 6-9 months to express substitution risk, since humanoids can expand the automation envelope while pressuring incumbent cycle-sensitive names.
• For higher convexity, buy 12-18 month call spreads on the most credible compute beneficiary rather than the robot maker itself; the best risk/reward is in the tools sold to everyone building the ecosystem.
• Monitor any listed Asian hardware names with supply-chain leverage; if Chinese pricing continues to collapse, fade Western hardware margins and rotate into software/compute where pricing power is more durable.